CYSLTR2 and asthma: Although CysLT2R-selective or dual antagonists have been introduced to treat severe asthma and brain injuries25,26, the development of CysLT2R-targeted drugs still faces challenges due to the lack of understanding of ligand recognition and receptor activation mechanism triggered by CysLTs.